https://www.marketscreener.com/quote/stock/MIRUM-PHARMACEUTICALS-INC-61871306/news/Mirum-Pharmaceuticals-oral-drug-becomes-first-U-S-approved-Alagille-syndrome-therapy-36551057/?utm_source=telegram&utm_medium=social&utm_campaign=share